The present invention includes bis- and tris-benzamide compounds that block AR signaling and have anticancer activity. Uses for these compounds, and pharmaceutical compositions containing the same, also are provided.Linvention concerne des composés bis- et tris-benzamide bloquant la signalisation AR et ayant une activité anticancéreuse, ainsi que lutilisation de ces composés et de compositions les renfermant.